Biosynch.ai
San Diego
About Biosynch.ai
BioSynch AI is an AI native drug discovery company that turns early drug R&D into an engineering workflow, combining advanced machine learning models, very large biological datasets, and an integrated wet lab, to design and advance new medicines faster and with higher odds of success.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $5.4M
- Funding stage: Seed
- Last round: Seed (Apr 2025)
- Website: biosynchai.com
- Phone: [email protected]
Canonical: https://fsome.com/organization/biosynch-ai-49958 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.